Clinical Trial Update: An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This open-label, multicenter Phase 3 follow-on study assesses the long-term safety and efficacy of Insulin VIAject in subjects with Type 1 diabetes mellitus; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin VIAject (insulin)

Snippet

Sponsor: Biodel | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED